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Identification and Characterization
of an IkB Kinase
Catherine H. ReÂ gnier, Ho Yeong Song, by Verma et al., 1995). To date, the identification of a
bona fide IkB-a kinase has remained elusive.Xiong Gao, David V. Goeddel,
The pleiotropic cytokines tumor necrosis factor (TNF)Zhaodan Cao, and Mike Rothe
and interleukin-1 (IL-1) are among the physiological in-Tularik, Inc.
ducers of IkB phosphorylation and subsequent NF-kBTwo Corporate Drive
activation (Osborn et al., 1989; Beg et al., 1993). Al-South San Francisco, California 94080
though TNF and IL-1 initiate signaling cascades leading
to NF-kB activation via distinct families of cell-surface
receptors (reviewed by Smith et al., 1994; Dinarello,Summary
1996), both pathways utilize members of the TNF recep-
tor±associated factor (TRAF) family of adaptor proteinsActivation of the transcription factor NF-kB by tumor
as signal transducers (Rothe et al., 1995a; Cao et al.,necrosis factor (TNF) and interleukin-1 (IL-1) requires
1996a; Hsu et al., 1996a). TRAF proteins associate di-the NF-kB-inducing kinase (NIK). In a yeast two-hybrid
rectly with the cytoplasmic domain of several membersscreen for NIK-interacting proteins, we have identified
of the TNF receptor family including the 75 kDa TNFa protein kinase previously known as CHUK. Overex-
receptor (TNFR2), CD40, and CD30 (Hu et al., 1994;
pression of CHUK activates a NF-kB-dependent re-
Rothe et al., 1994; Cheng et al., 1995; Mosialos et al.,
porter gene. A catalytically inactive mutant of CHUK 1995; Gedrich et al., 1996; Lee et al., 1996). In addition,
is a dominant-negative inhibitor of TNF-, IL-1-, TRAF-, TRAF proteins are recruited indirectly to the 55 kDa
and NIK-induced NF-kB activation. CHUK associates TNF receptor (TNFR1) and the related DR3/Wsl by the
with the NF-kB inhibitory protein, IkB-a, in mammalian receptor-associated adaptor protein TRADD (Chinnai-
cells. CHUK specifically phosphorylates IkB-a on both yan et al, 1996a; Hsu et al., 1996a; Kitson et al., 1996;
serine 32 and serine 36, modifications that are required Shu et al., 1996). TNFR1- and presumably DR3/Wsl-
for targeted degradation of IkB-a via the ubiquitin- mediated NF-kB activation also require the serine-threo-
proteasome pathway. This phosphorylation of IkB-a nine kinase RIP (Stanger et al., 1995; Ting et al., 1996),
is greatly enhanced by NIK costimulation. Thus, CHUK which associates with the respective receptor com-
is a NIK-activated IkB-a kinase that links TNF- and IL- plexes via TRADD and also interacts with TRAF proteins
1-induced kinase cascades to NF-kB activation. (Chinnaiyan et al., 1996a; Hsu et al., 1996b). Three of
the six describedTRAF family members have been impli-
cated in NF-kB activation. TNF-induced NF-kB activa-Introduction
tion requires TRAF2 (Rothe et al., 1995a; Hsu et al.,
1996a). TRAF5 is also involved in NF-kB activation byThe activityof themammalian transcription factorNF-kB
members of the TNF receptor family (Ishida et al., 1996;(nuclear factor kB) is tightly regulated by cytokines and
Nakano et al., 1996). In contrast, TRAF6 participatesother external stimuli (reviewed by Baeuerle and Henkel,
in NF-kB activation by IL-1 (Cao et al., 1996a). TRAF61994; Thanos and Maniatis, 1995; Verma et al., 1995).
associates with the serine-threonine kinase IRAK follow-NF-kB is composed of homo- and heterodimers of mem-
ing the IL-1-induced activation of IRAK in the IL-1 recep-bers of the Rel family of related transcription factors
tor complex (Cao et al., 1996b; Huang et al., submitted).that control the expression of numerous immune and
The NF-kB-inducing kinase (NIK) is a member of theinflammatory response genes as well as important viral
MAP kinase kinase kinase (MAP3K) family that was iden-genes (reviewed by Lenardo and Baltimore, 1989;
tified as a TRAF2-interacting protein (Malinin et al.,Baeuerle and Henkel, 1994; Baeuerle and Baltimore,
1997). NIK activates NF-kB when overexpressed, and1996). In most cell types, NF-kB is present as a hetero-
kinase-inactive mutants of NIK comprising its TRAF2-
dimer comprising a 50 kDa (p50) and a 65 kDa subunit
interacting C-terminal domain [NIK(624±947)] or lacking the(p65) that is sequestered in the cytoplasm by a member
two lysine residues in its catalytic domain [NIK(KK429±430AA)]of the IkB family of inhibitory proteins (reviewed by behave as dominant-negative inhibitors that suppress
Baeuerle and Henkel, 1994; Thanos and Maniatis, 1995; TNF-, IL-1-, TRADD-, RIP-, and TRAF2-induced NF-kB
Verma et al., 1995). IkB proteins mask the nuclear local- activation (Malinin et al., 1997). Recently, NIK was found
ization signal of NF-kB, thereby preventing NF-kB nu- to associate with additional members of the TRAF fam-
clear translocation. Conversion of NF-kB into an active ily, including TRAF5 and TRAF6 (Song et al., 1997). Cata-
transcription factor that translocates into the nucleus lytically inactive mutants of NIK also inhibit TRAF5- and
and binds to cognate DNA sequences entails the signal- TRAF6-induced NF-kB activation, thus providing a uni-
induced phosphorylation of IkB proteins on specific ser- fying concept for NIK as a common mediator in the
ine residues, such as serines 32 and 36 of IkB-a and NF-kB signaling cascades triggered by TNF and IL-1
serines 19 and 23 of IkB-b (reviewed by Verma et al., downstream of TRAFs and other receptor-associated
1995). Subsequent to phosphorylation, IkB proteins are signaling proteins (Song et al., 1997). Whereas TRAF2
ubiquitinated and degraded through a proteasome- is involved in the activation of both NF-kB and the c-Jun
dependent pathway (reviewed by Thanos and Maniatis, N-terminal kinase (JNK, or SAPK) by TNF, NIK does not
1995). Although several kinases have been implicated activate the JNK pathway but is dedicated to NF-kB
in the phosphorylation of IkB-a, none has been shown activation (Song et al., 1997). However, NIK itself does
not appear to be an IkB-a kinase (see below).to phosphorylate both serine 32 and serine 36 (reviewed
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Here, we report the identification of CHUK, a pre- Interaction of CHUK and NIK in Human Cells
The interaction of CHUK with NIK was further analyzed inviously described serine-threonine kinase of unknown
mammalian cell coimmunoprecipitation assays. Humanfunction (Connelly and Marcu, 1995), in a yeast two-
CHUK containing an N-terminal Flag epitope tag washybrid screen for NIK-interacting proteins. CHUK
transiently coexpressed in 293 human embryonic kidneyactivates a NF-kB-dependent reporter gene when over-
cells with either Myc epitope±tagged NIK or HA epitope±expressed. A catalytically inactive mutant of CHUK sup-
tagged TRAF2. Cell lysates were immunoprecipitatedpresses NF-kB activation induced by TNF and IL-1
using a monoclonal antibody against the Flag epitope,stimulation as well as by TRAF2, TRAF6, and NIK overex-
and coprecipitating NIK or TRAF2 were detected bypression. CHUK associates with both NIK and IkB-a in
immunoblot analysis with anti-Myc or anti-HA polyclonalmammalian cells. CHUK phosphorylates IkB-a on ser-
antibodies, respectively. In this assay, CHUK was ableines 32 and 36, and this phosphorylation is strongly
to coprecipitate NIK (Figure 2A, lane 6), confirming theenhanced by NIK costimulation. These findings demon-
interaction detected by yeast two-hybrid analysis. Cata-strate that CHUK is an IkB-a kinase that directly associ-
lytically inactive mutants of CHUK (see below) con-ates with and is activated by NIK.
taining an alanine substitution of a conserved lysine
residue in its kinase domain [CHUK(K44A)] or lacking the
entire N-terminal kinase domain [CHUK(307±745)] were alsoResults
able to associate with NIK, indicating that the a-helical
C-terminal half of CHUK mediates the interaction withIdentification of CHUK as a NIK-Associating
NIK (Figure 2A, lanes 12 and 16). In contrast to NIK,Protein Kinase
CHUK failed to associate with TRAF2 (Figure 2A; com-To identify the downstream target(s) of NIK required for
pare lanes 4 and 20). To determine if NIK can mediatecytokine-mediated NF-kB activation, we screened for
an indirect interaction between CHUK and TRAF2, theproteins that associate directly with NIK by yeast two-
three proteins were coexpressed simultaneously in 293hybrid protein interaction cloning (Fields and Song,
cells. Whereas NIK±CHUK interaction remained strong,1989). An expression vector that encodes NIK fused to
only a very weak coprecipitation of TRAF2 with CHUKthe DNA-binding domain of theyeast transcription factor
was detected in the presence of NIK (Figure 2A, lane 8).GAL4 was used as bait in a two-hybrid screen of a
This finding suggests that a ternary complex consistinghuman B cell cDNA library. From approximately five
of CHUK, NIK, and TRAF2 either does not form or formsmillion transformants, six independent positive clones
only transiently.were obtained, as determined by activation of his and
The programmed expression in 293 cells of CHUK,lacZ reporter genes. Two of these clones encoded
NIK, and TRAF2 was further characterized by immu-TRAF3, a member of the TRAF family (Hu et al., 1994;
noblotting of aliquots of cell lysates (Figure 2B). ThisCheng et al., 1995; Mosialos et al., 1995). One clone
analysis revealed that CHUK migrates more slowly inencoded the previously isolated conserved helix-loop-
SDS±polyacrylamide gel electrophoresis (PAGE) whenhelix ubiquitous kinase (CHUK; Connelly and Marcu,
expressed with NIK than when expressed alone or with1995), a serine-threonine kinase of unknown function.
TRAF2 (Figure 2B; compare lanes 2±4). This was notThe interaction between NIK and CHUK was verified by
observed for kinase-inactive CHUK(K44A) or CHUK(307±745)retransformation into yeast cells (data not shown).
(Figure 2B, lanes 6±9). Similarly, whereas overexpressedThe 59-end of the human CHUK two-hybrid clone cor-
NIK was detected as a doublet of bands of 110 and 120responds to amino acid 23 of mouse CHUK (Connelly
kDa when expressed alone or with TRAF2, CHUK(K44A),and Marcu, 1995) and extends the partially described
or CHUK(307±745), it migrated as a single band of 130 kDaamino acid sequence of human CHUK (Connelly and
when coexpressed with wild-type CHUK (Figure 2B;
Marcu, 1995) by nine amino acids (Figure 1). Subse-
compare lanes 4, 7, and 9±11). As has been described
quently, a full-length human CHUK clone was isolated
for IkB proteins (reviewed by Verma et al., 1995) (see
by screening a Jurkat T cell cDNA library (Figure 1). DNA also below) and IRAK (Cao et al., 1996b), the reduced
sequence analysis of the CHUK cDNA and two-hybrid mobility of coexpressed CHUK and NIK may represent
clones revealed an open reading frame predicted to phosphorylated forms of both proteins generated by
encode a protein of 745 amino acids (Figure 1). We their functional interaction (see below). The migration
found six differences in the amino acid sequence of of TRAF2 was also slightly shifted and became more
the deduced human CHUK protein compared to the diffuse when coexpressed with NIK and CHUK simulta-
previously described partial amino acid sequence of neously compared to its migration when expressed with
human CHUK (Connelly and Marcu, 1995). These differ- either kinase separately (Figure 2B; compare lanes 3, 5,
ences are at residues 604 (Leu versus Arg), 679 (Thr and 11). Together, these data suggest that TRAF2 may
versus Ala), 680 (Ser versus Tyr), 684 (Pro versus Ala), be phosphorylated by, and subsequently released from,
686 (Thr versus Asp), and 687 (Ser versus Leu) (Figure 1). the NIK±CHUK complex.
Human and mouse CHUK are 96% identical at the
amino acid level (Figure 1). Both proteins comprise an
N-terminal serine-threonine kinase catalytic domain, a Effect of Wild-Type and Mutant CHUK
C-terminal helix-loop-helix domain, and a leucine zip- on NF-kB Activation
per-like amphipathic a-helix juxtaposed between the To investigate a possible role for CHUK in NF-kB activa-
helix-loop-helix and kinase domain (Connelly and tion, we examined if transient overexpression of CHUK
might activate an NF-kB-dependent reporter gene. AnMarcu, 1995) (Figure 1).
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Figure 1. Homology between Human and Mouse CHUK
An optimized alignment of the protein sequences of human and mouse CHUK is shown. Identical amino acids are boxed. The arrow indicates
the 59-end of the CHUK two-hybrid cDNA clone. Brackets delineate the boundaries of the kinase domain. Asterisks mark residues that are
different from the previously described partial amino acid sequence of human CHUK (Connelly and Marcu, 1995).
E-selectin-luciferase reporter construct and a CHUK ex- In Vitro Phosphorylation of IkB by CHUK
pression vector were cotransfected into HeLa cells. To investigate if CHUK might phosphorylate members
Overexpression of CHUK activated the reporter gene in of the IkB family, we utilized an in vitro phosphorylation
a dose-dependent manner, with a maximal induction of assay. Epitope-tagged CHUK was transiently expressed
luciferase activity of 15-fold compared to vector control in 293 cells, immunoprecipitated with anti-Flag antibody
(Figure 3A). Similar results were obtained in 293 cells immunoaffinity resin, and eluted from the beads with
where CHUK activated the reporter gene 6- to 7-fold Flag peptide. Eluted CHUK and bacterially expressed
(data not shown). Thus, CHUK induces modest NF-kB recombinant IkB-a comprising amino acids 1±250 of
activation when overexpressed. TNF or IL-1 treatment IkB-a [IkB-a(1±250)] were incubated with [g-32P]-ATP. In this
slightly stimulated the NF-kB-inducing activity of over- assay, both CHUK and IkB-a(1±250) were phosphorylated
expressed CHUK in transient reporter gene assays at (Figure 4A). We next determined the specificity of IkB-a
low concentrations of transfected DNA (Figure 3A). phosphorylation by CHUK. CHUK phosphorylated ver-
Unlike wild-type CHUK, the catalytically inactive sions of IkB-a(1±250) in which either serine 32 or serine 36
CHUK(K44A) mutant did not activate the NF-kB-dependent alone were mutated to alanine (Figure 4A). However,
reporter gene when overexpressed (Figure 3B). There- CHUK was unable to phosphorylate a version of IkB-
fore, we determined its effect on signal-induced NF-kB
a(1±250) in which both serine 32 and serine 36 were re-activation in reporter gene assays in 293/IL1-RI cells
placed by alanines (Figure 5A). In contrast to wild-type
(Cao et al., 1996b). Overexpression of CHUK(K44A) blocked CHUK, similarly expressed and purified CHUK(K44A) didTNF- and IL-1-induced reporter gene activation (Figure
not phosphorylate itself or IkB-a(1±250) (Figure 4A). Thus,3B). CHUK(K44A) also inhibited NF-kB-dependent reporter
CHUK specifically phosphorylates IkB-a on serines 32gene activity elicited by overexpression of TRAF2,
and 36.TRAF6, and NIK in 293 cells (Figure 3C). The effect of
CHUK also phosphorylated a bacterially expressedCHUK(K44A) on the weaker NF-kB activators TRAF2 and
protein comprising amino acids 1±311 of IkB-b [IkB-TRAF6 was more pronounced than its effect on the
b(1±311)] but not a version of IkB-b(1±311) containing alaninesstronger activator NIK (Figure 3C). Taken together, these
at the inducible phosphorylation sites serine 19 and ser-results demonstrate that a catalytically inactive CHUK
ine 23 (Figure 4A). However, CHUK's phosphorylationmutant is a dominant-negative inhibitor of TNF-, IL-1,
of a version of IkB-b(1±311) in which serine 19 is replacedTRAF-, and NIK-induced NF-kB activation. This sug-
by alanine was significantly stronger than phosphoryla-gests that CHUK functions downstream of NIK as a
common mediator of NF-kB activation by TNF and IL-1. tion of a version in which serine 23 is mutated to alanine
Cell
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Figure 2. Interaction of CHUK with NIK and
TRAF2
(A) Immunoprecipitation of wild-type and mu-
tant CHUK. 293 cells were transiently trans-
fected with the indicated amounts (in micro-
grams) of expression vectors encoding Flag
epitope±tagged CHUK (lanes 1±8), CHUK(K44A)
(lanes 9±12), CHUK(307±745) (lanes 13±16), or NIK
(lanes 17±20) and expression plasmids en-
coding Myc epitope±tagged NIK (lanes 5±8,
11, 12, 15, and 16) or HA epitope±tagged
TRAF2 (lanes 7, 8, 19, and 20) as described
in Experimental Procedures. After 24 hours,
cell lysates were prepared and incubated
with anti-Flag monoclonal antibody (lanes la-
beled [aF]) or control monoclonal antibody
(lanes labeled [C]). Coprecipitating Myc epi-
tope±tagged NIK and HA epitope±tagged
TRAF2 were detected by immunoblot analy-
sis using anti-Myc and anti-HA polyclonal an-
tibodies. Arrows mark the positions of NIK
and TRAF2.
(B) Immunoblot analysis of total cell extracts.
Aliquots of total cell extracts (10 ml) of the
transfections in (A) were immunoblotted with
anti-Flag, anti-Myc, and anti-HA polyclonal
antibodies as described in Experimental Pro-
cedures. The positions of NIK, CHUK, and
TRAF2 are marked.
Positions of molecular mass standards (in ki-
lodaltons) are shown on the left in both
panels.
(Figure 4A). This indicates that CHUK preferentially and 36 werereplaced by alanines [IkB-a(S32,36A)] on a much
smaller scale than in the above described experimentphosphorylates serine 23 over serine 19 in IkB-b.
We next examined if NIK can potentiate the activity (see Experimental Procedures). Immunoblot analysis of
anti-Flag immunoprecipitates resulted in no detectableof CHUK to phosphorylate IkB-a(1±250) in vitro using coex-
pressed and copurified Flag epitope±tagged CHUK and interaction between CHUK and IkB-a (Figure 5B, lanes
4 and 5 in the top panel). However, when coexpressedMyc epitope±tagged NIK. In these assays, the phos-
phorylation of both CHUK and IkB-a(1±250) was greatly with the p65 and p50 subunits of NF-kB, both IkB-a and
IkB-a(S32,36A) coprecipitated with CHUK (Figure 5B, lanesenhanced in the presence of wild-type NIK but not cata-
lytically inactive NIK(KK429±430AA) (Figure 4B). These results 6 and 7 in the top panel). Similarly, upon coexpression of
CHUK and p65-p50, endogenous IkB-a coprecipitatedindicate that NIK phosphorylates CHUK and thereby
stimulates CHUK's ability to phosphorylate IkB-a (see weakly with CHUK (Figure 5, lane 3 in the top panel).
This association was apparently not mediated by analso below).
interaction of CHUK with p65-p50, since we could not
observe coprecipitation of CHUK and p65-p50 in theAssociation of CHUK with IkB-a
To determine if CHUK associates with IkB-a, 293 cells absence of IkB-a (data not shown). Rather, immunoblot
analysis of aliquots of cell lysates demonstrated thatwere transfected with a Flag epitope±tagged CHUK ex-
pression vector. After 24 hours, cells were harvested, coexpression of p65-p50 appears to stabilize overex-
pressed IkB-a (Figure 5B; compare lanes 4 and 5 withand lysates prepared and immunoprecipitated with anti-
Flag monoclonal antibody or control antibody. Immu- lanes 6 and 7 in the lower panel). This finding is in
agreement with earlier observations that IkB-a is rapidlynoblot analysis with anti-IkB-a antibodies showed that
IkB-a coprecipitates with CHUK (Figure 5A). Thus, over- degraded when not complexed with NF-kB (Scott et al.,
1993). Thus, CHUK associates with IkB-a bound to p65-expressed CHUK associates with the endogenous IkB-a
complex in mammalian cells. p50.
Induced phosphorylation of IkB-a on serines 32 andTo investigate if the detected interaction of CHUK with
IkB-a is direct or mediated by other endogenous factors, 36 reduces its mobility in PAGE, and the slower migrat-
ing IkB-a species can be detected by immunoblot analy-Flag epitope±tagged CHUK was coexpressed in 293
cells with wild-type or mutant IkB-a in which serines 32 sis (Verma et al., 1995). We were not able to detect
IKK-b Is a NIK-Interacting IkB Kinase
377
such phosphorylation of IkB-a by overexpressed CHUK
(Figure 5B, lane 6 in the lower panel). This result is
consistent with the moderate NF-kB-inducing activity
of CHUK in reporter gene assays (see above), which
suggests that only a small amount of IkB-a may be
phosphorylated (and most likely subsequently de-
graded). However, the addition of NIK strongly induced
phosphorylation of IkB-a as evidenced by the conver-
sion of the majority of the overexpressed IkB-a into a
more slowly migrating form (Figure 5B, lanes 8 and 28
in the lower panel). This did not occur with overex-
pressed IkB-a(S32,36A) (Figure 5B, lanes 9 and 29 in the
lower panel), although a small amount of background
phosphorylation of both IkB-a(S32,36A) and wild-type IkB-a
was detected resulting in a slightly faster migrating form
compared to the majority of the phosphorylated wild-
type IkB-a (Figure 5B, compare lanes 8 and 9, and 28
and 29 in the lower panel). The stimulation of IkB-a
phosphorylation by NIK was dependent on catalytically
active CHUK, since it was not observed when NIK was
coexpressed with CHUK(K44A) (Figure 5B, lane 18 in the
lower panel). Nevertheless, this mutant CHUK protein
can still associate with NIK (Figure 2A) and IkB-a (Figure
5B). Kinase-inactive NIK did not stimulate IkB-a phos-
phorylation (Figure 5B, lanes 10 and 30 in the lower
panel). In contrast to CHUK, NIK itself did not interact
with IkB-a coexpressed with p65-p50 (Figure 5B; com-
pare upper and lower panels in lanes 26 and 27). How-
ever, NIK did coprecipitate IkB-a when coexpressed
with CHUK and p65-p50 (Figure 5B, lanes 28 and 29 in
the upperpanel). Taken together, these findings demon-
strate that CHUK binds directly to both NIK and the
IkB-a±p65-p50 complex and that CHUK's ability to
phosphorylate IkB-a is greatly stimulated by NIK.
Although coexpression of CHUK, NIK, IkB-a, and p65-
p50 strongly induced IkB-a phosphorylation (Figure 5B,
lanes 8 and 28 in the bottom panel), this phosphorylated
Figure 3. Role of CHUK in NF-kB Activation form of IkB-a did not coprecipitate with CHUK (Figure
(A) Effect of CHUK expression on NF-kB-dependent reporter gene 5B; compare top and bottom panels in lanes 8 and 28).
activity in HeLa cells. HeLa cells were transiently cotransfected with In contrast, unphosphorylated and the small amount
an E-selectin-luciferase reporter gene plasmid and vector control of background phosphorylated IkB-a and IkB-a(S32,36A)
or a CHUK expression vector as indicated. Thirty-six hours after remained associated with CHUK in immunoprecipita-
transfection, cells were either left untreated (closed bars) or stimu-
tions (Figure 5B; compare top and bottom panels inlated for 6 hours with TNF (100 ng/ml) (open bars) or IL-1 (10 ng/
lanes 8 and 9, and 28 and 29). This suggests that onceml) (hatched bars) prior to harvest. Luciferase activities were deter-
IkB-a is phosphorylated on serines 32 and 36, it is re-mined and normalized on the basis of b-galactosidase expression.
leased from the CHUK±NIK complex.(B) Effect of CHUK(K44A) expressionon TNF- andIL-1-induced reporter
gene activity in 293/IL-1RI cells. 293/IL-1RI cells (Cao et al., 1996b)
were transiently cotransfected with an E-selectin-luciferase reporter
gene plasmid and vector control or a CHUK(K44A) expression vector Discussion
as indicated. Thirty-six hours after transfection, cells were either
left untreated (open bars) or stimulated for 6 hours with TNF (100
The recent identification of the MAP3K-related serine-
ng/ml) (closed bars) or IL-1 (10 ng/ml) (hatched bars) prior to harvest.
threonine kinase NIK provided an important link in theLuciferase activities were determined and normalized on the basis
TNF- and IL-1-induced NF-kB activation pathwaysof b-galactosidase expression.
downstream of members of the TRAF family (Malinin et(C) Effect of CHUK(K44A) expression on NIK- and TRAF-induced re-
porter gene activity in 293 cells. 293 cells were transiently cotrans- al., 1997). In a search for targets of NIK-mediated NF-
fected with an E-selectin-luciferase reporter gene plasmid; expres- kB activation, we have identified the serine-threonine
sion vectors for NIK (open bars), TRAF2 (closed bars), or TRAF6 kinase CHUK (Connelly and Marcu, 1995) as a NIK-inter-
(hatched bars); and a CHUK(K44A) expression plasmid as indicated. acting protein. CHUK displays the characteristics ex-
Thirty-six hours after transfection, cells were collected and lucifer-
pected of a cytokine-inducible IkB kinase. It associates
ase activities determined and normalized on the basis of b-galacto-
with the IkB-a complex and specifically phosphorylatessidase expression. The fold induction in luciferase activity compared
IkB-a on both serine 32 and serine 36, modificationswith the control vector transfection is shown.
that are required for signal-induced ubiquitination andValues shown in all panels are averages for one representative ex-
periment in which each transfection was performed in duplicate. degradation of IkB-a. The ability of CHUK to activate
Standard errors are less than 5%. NF-kB is greatly stimulated by NIK, and a catalytically
Cell
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Figure 4. In Vitro Phosphorylation of IkB Proteins by CHUK
(A) Specificity of IkB phosphorylation by CHUK. 293 cells were transiently transfected with vector control (lanes 1±4 and 17) or expression
plasmids for Flag epitope±tagged CHUK (lanes 5±8, 13±16, and 18) or CHUK(K44A) (lanes 9±12 and 19). Twenty-four hours after transfection,
CHUK proteins were immunoprecipitated with anti-Flag monoclonal antibody affinity resin andpurified as described in ExperimentalProcedures.
Purified CHUK proteins and bacterially expressed IkB-a (1±250) proteins (lanes 1±12) or IkB-b(1±311) proteins (lanes 13±16) were incubated with [g-
32P]-ATP as indicated by (1), resolved by SDS±PAGE, and analyzed by autoradiography. The amounts of CHUK and CHUK(K44A) used in the
reactions were determined by immunoblotting with anti-Flag polyclonal antibodies (lanes 17±19). Arrows mark the positions of CHUK proteins,
IkB-a (1±250) proteins, and IkB-b(1±311) proteins.
(B) Costimulation of IkB-a phosphorylation by NIK. 293 cells were transiently transfected with expression plasmids for Flag epitope±tagged
CHUK (lanes 1, 3±5, 7, and 8) or CHUK(K44A) (lanes 2 and 6) and Myc epitope±tagged NIK (lanes 3 and 7) or NIK(KK429±430AA) (lanes 4 and 8). CHUK
proteins (and coprecipitating NIK proteins) were purified, and in vitro phosphorylation reactions with bacterially expressed IkB-a(1±250) (lanes
1±4) performed as in (A). The amounts of CHUK and CHUK(K44A) used in lanes 1±4 were determined by immunoblotting with anti-Flag polyclonal
antibodies (lanes 5±8). Arrows mark the positions of NIK, CHUK proteins, and IkB-a(1±250). Note that lanes 1±4 are underexposed compared to
(A) with respect to IkB-a (1±250) phosphorylation by CHUK in lane 1 to visualize the costimulation of CHUK and IkB-a(1±250) phosphorylation by
NIK.
Positions of molecular mass standards (in kilodaltons) are shown on the left in all panels.
inactive mutant of CHUK suppresses TNF-, IL-1-, TRAF-, to and phosphorylates IkB-a, which is subsequently de-
graded via the ubiquitin-proteasome pathway culminat-and NIK-induced NF-kB activation. In addition, CHUK
is expressed ubiquitously (Connelly and Marcu, 1995), ing in the translocation of NF-kB into the nucleus (re-
viewed by Thanos and Maniatis, 1995; Verma et al.,which is in agreement with the pleiotropic roles of NF-kB
in many different cell types and tissues (reviewed by 1995).
Several other responses triggered by TNF utilize dis-Lenardo and Baltimore, 1989; Baeuerle and Henkel,
1994; Baeuerle and Baltimore, 1996). Based on its newly tinct components of the NF-kB pathway but diverge at
discrete levels (Figure 6). TRADD also mediates TNF-established functional properties, we propose to desig-
nate CHUK as ªIkB kinase-aº (IKK-a). induced apoptosis (Hsu et al., 1995) through its associa-
tion with FADD (Boldin et al., 1995; Chinnaiyan et al.,IKK-a connects the signal transduction pathway that
is initiated at the cytoplasmic domain of TNFR1 to the 1995, 1996b; Hsu et al., 1996a), which activates a cas-
pase cascade via caspase-8 (Boldin et al., 1996; Muzioactivation and nuclear translocation of NF-kB. This path-
way consists of a cascade of protein±protein interac- et al., 1996). TNF-induced activation of JNK/SAPK bifur-
cates from the NF-kB pathway at the level of TRAF2tions that delineate a functional hierarchy among its
components (Figure 6). Upon binding of TNF to TNFR1, (Liu et al., 1996; Song et al., 1997). An anti-apoptotic
pathway is also initiated at TRAF2 by association withthe adaptor protein TRADD is recruited to the cyto-
plasmic domain of TNFR1 via interaction of the death members of the inhibitor of apoptosis protein (IAP) fam-
ily (Rothe et al., 1995b; Liston et al., 1996; Orth and Dixit,domains of both proteins (Hsu et al., 1995; Shu et al.,
1996). TRADD mediates the association of the death 1997), and NF-kB itself induces responses that protect
against apoptosis (Van Antwerp et al., 1996; Beg anddomain±containing serine-threonine kinase RIP and
TRAF2 with the TNFR1 signaling complex (Hsu et al., Baltimore, 1996; Liu et al., 1996; Wang et al., 1996).
NIK is the first component of the TNF-induced NF-kB1996a, 1996b). TRAF2 and RIP also bind to each other
(Hsu et al., 1996b). TRAF2 interacts with NIK (Malinin et pathway that appears exclusively dedicated to NF-kB
activation. This is supported by the observation thatal., 1997), and NIK associates with IKK-a. IKK-a binds
IKK-b Is a NIK-Interacting IkB Kinase
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Figure 5. Association of CHUK and IkB-a
(A) Coprecipitation of endogenous IkB-a with overexpressed CHUK. 293 cells (4.8 3 107) were transiently transfected with vector control
(lanes 1 and 2) or an expression plasmid encoding Flag epitope±tagged CHUK (lanes 3 and 4) as described in Experimental Procedures.
Twenty-four hours later, cell lysates were prepared and incubated with anti-Flag monoclonal antibody ([aFlag]; lanes 2 and 3) or control
monoclonal antibody ([C]; lanes 1 and 3). Coprecipitating IkB-a was detected by immunoblot analysis with anti-IkB-a polyclonal antibodies.
The position of IkB-a is marked by an arrow.
(B) Coprecipitation of overexpressed IkB-a and CHUK. 293 cells (2 3 106) were transiently transfected with vector control alone (lane 1) or
with the indicated amounts (in micrograms) of plasmids directing the expression of Flag epitope±tagged CHUK (lanes 2±11), CHUK(K44A) (lanes
12±21) or NIK (lanes 22±31), Myc epitope±tagged CHUK (lanes 28 and 29), CHUK(K44A) (lanes 30 and 31), NIK (lanes 8, 9, 18, and 19), or
NIK(KK429±430AA) (lanes 10, 11, 20, and 21), and untagged IkB-a (lanes 4, 6, 8, 10, 14, 16, 18, 20, 24, 26, 28, and 30), IkB-a(S32,36A) (lanes 5, 7, 9, 11,
15, 17, 19, 21, 25, 27, 29, and 31) and p65-p50 (lanes 3, 6±11, 13, 16±21, 23, and 26±31). After 24 hours, cell lysates were incubated with anti-
Flag monoclonal antibody. Coprecipitating IkB-a was detected by immunoblot analysis with anti-IkB-a polyclonal antibodies (upper panel).
Aliquots of total cell extracts (10 ml) of the same transfections were also immunoblotted with anti-IkB-a polyclonal antibodies (lower panel).
Lanes 22±31 of the upper panel show a 5 minute exposure whereas all other lanes in both panels were exposed for 1 minute. Note that the
immunoprecipitations were performed in smaller-scale cell lysates than in (A) (see Experimental Procedures). Arrows mark the positions of
unphosphorylated IkB-a proteins and of IkB-a phosphorylated on serines 32 and 36 (see text for details).
Positions of molecular mass standards (in kilodaltons) are shown on the left in all panels.
NF-kB signaling cascades initiated by multiple recep- stimulation induces the formation of a complex between
IRAK and TRAF6 that is dissociated from the IL-1 recep-tors converge at NIK (Malinin et al., 1997). A prominent
example is the IL-1-induced NF-kB pathway (Figure 6). tor complex (Cao et al., 1996a). Like TRAF2, TRAF6
binds to NIK (Song et al., 1997), thereby linking NIK andIL-1-mediated aggregation of the IL-1 receptor 1 (IL-
1RI) and the IL-1 receptor accessory protein (IL-1RAcP) subsequently IKK-a to both IL-1- and TNF-induced NF-
kB activation. Existing evidence suggests that the NF-leads to activation of the serine-threonine kinase IRAK,
which is recruited to the IL-1 receptor complex by IL- kB activation pathways initiated by other members of
the TNF receptor family, including TNFR2, CD40, and1RAcP (Cao et al., 1996b; Huang et al., submitted). IL-1
Figure 6. A Model for the NF-kB Signal
Transduction Pathways Initiated by TNF and
IL-1
See text for details.
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CD30, also proceed through NIK-IKK-a since they asso- understood. Based on NIK's association with members
ciate directly with members of the TRAF family that of the TRAF family, cytokine-induced receptor activation
activate NF-kB and bind NIK (Rothe et al., 1995a; Ged- may cause conformational changes in TRAFs involving
rich et al., 1996; Ishida et al., 1996; Lee et al., 1996; their zinc finger domains that result in NIK activation.
Nakano et al., 1996; Song et al., 1997). Alternatively, it is conceivable that multiple kinases, in-
The mechanisms of NF-kB activation following IkB cluding RIP and IRAK, via interactions with TRAFs, could
phosphorylation and degradation have been elucidated phosphorylate and activate NIK. In this case, TRAFs
in detail (reviewed by Thanos and Maniatis, 1995; Verma might act as scaffolding components, similar to the
et al., 1995). The present study defines IKK-a as the yeast protein STE5, which functions as a scaffolding
first kinase that can phosphorylate IkB-a at the two protein that binds components of the yeast MAP kinase
appropriate serine residues. These results were ob- cascade via nonoverlapping regions and imparts speci-
tained with IKK-a immunoprecipitates and therefore ficity by juxtaposing all members of a particular cascade
leave the formal possibility that the detected IkB-a phos- (Choi et al., 1994). However, the kinase domain of RIP
phorylation is mediated by another kinase that is acti- does not appear to be required for TNF-mediated NF-kB
vated by IKK-a. Further proofof a directphosphorylation activation (Hsu et al., 1996b; Ting et al., 1996).
of IkB-a by IKK-a will require bacterially expressed re- Recently, the biochemical characterization of a large,
combinant proteins. However, in mammalian cells, over- multisubunit, ubiquination-inducible IkB-a kinase com-
expressed IKK-a (but not NIK) associates strongly with plex of approximately 700 kDa has been described
overexpressed IkB-a (when complexed with NF-kB) and (Chen et al., 1996). Although not directly addressed by
therefore this interaction is unlikely to be mediated by the present study, IKK-a likely constitutes one of the
another, endogenous kinase. In addition, IKK-a (but not components of this complex. However, to date we have
NIK) interacts directly with IkB-a in the yeast two-hybrid no evidence that ubiquitination is required for IKK-a
system (C. H. R. and M. R., unpublished data). Taken activation. Perhaps the ubiquitination requirement is
together, thesefindings characterize IKK-a as a catalytic only obvious when IKK-a is present in the context of
subunit of the IkB-a kinase complex. We also provide the entire endogenous IkB kinase complex. Our results
evidence that upon phosphorylation IkB-a is released suggest that the minimal complex required for phos-
from IKK-a. phorylation of IkB-a comprises IKK-a, NIK, NF-kB, and
Recently, the mitogen-activated 90 kDa ribosomal S6
IkB-a. An IkB-a kinase complex similar to the ubiquina-
kinase (p90rsk1) was implicated in NF-kB activation by
tion-inducible IkB-a kinase complex was reported to
mitogenic stimuli such as phorbol esters (Schouten et
be activated through phosphorylation by MEKK1, a
al., 1997). p90rsk1 was shown to associate with IkB-a
MAP3K-related kinase of the JNK pathway, and MEKK1
when coexpressed in mammalian cells, but in contrast
was found to be required for NF-kB activation by TNF
to IKK-a, it phosphorylates only serine 32 but not serine
(Lee et al., 1997). In contrast, two other studies have36 of IkB-a. Phorbol ester treatment caused the dissoci-
shown that MEKK1 or a MEKK1-related kinase is in-ation of p90rsk1 and IkB-a. A mutant p90rsk1 protein that
volved in TNF-induced JNK activation but not NF-kBwas unable to phosphorylate IkB-a suppressed NF-kB
activation (Liu et al., 1996; Song et al., 1997). The resultsactivation by phorbol esters but not TNF in mammalian
presented here are consistent with MEKK1 being dis-cells. It was therefore postulated that different NF-kB-
pensible for TNF-induced NF-kB activation.inducing signals activate distinct IkB-a kinases (Schouten
The CHUK gene was previously shown to be highlyet al., 1997). We currently do not knowif IKK-a is involved
conserved with weakly cross-hybridizing bands ob-in NF-kB activation by mitogens such as phorbol esters
served by Southern blot analysis in frog, fruit fly, and(or bacterial lipopolysaccharide). However, phosphory-
yeast (Connelly and Marcu, 1995). In light of the func-lation of IkB-a on both serine 32 and serine 36 has been
tional identification of CHUK as an IkB kinase, it willimplicated in its induced degradation by phorbol esters
be of interest to elucidate the role of CHUK genes in(Brockmann et al., 1995; Traenckner et al., 1995).
divergent species. Finally, mapping of the CHUK geneMembers of the MAP3K family typically signal down-
in the mouse genome revealed the existence of a CHUK-stream responses through activation of protein kinase
related sequence (Mock et al., 1995). Thus, it is possiblecascades comprising two additional kinase steps (re-
that IKK-a may represent the first member of a familyviewed by Robinson and Cobb, 1997). Although NIK is a
of related IkB kinases.MAP3K-related kinase, it distinguishes itself from other
known members of this kinase family by activating its
Experimental Procedurestarget, the IkB±NF-kB complex, through a single-step
kinase pathway. The kinase involved, IKK-a, is unrelated
Biological Reagents and Cell Culture
to either MAP kinase kinases or MAP kinases. Thus, the Recombinant human TNF and IL-1 were provided by Genentech,
NIK-IKK-a cascade represents a novel MAP3K signaling Incorporated (South San Francisco, CA). The anti-Flag monoclonal
pathway. antibody M2 and purified Flag peptide were purchased from East-
Our analysis of NIK and IKK-a suggests that NIK acti- man Kodak Company (New Haven, CT). Rabbit anti-IkB-a as well
as anti-Flag, anti-Myc, and anti-HA polyclonal antibodies were fromvates or at least strongly stimulatesIKK-a by phosphory-
Santa Cruz Biotechnology (Santa Cruz, CA). Human embryonic kid-lation. We also show that in overexpression experiments
ney 293 cells and HeLa cells were maintained as described (Hsu etcontaining IKK-a, NIK, and TRAF2, IKK-aand NIK remain
al., 1995).
associated whereas TRAF2 is phosphorylated and no
longer binds to NIK. How NIK itself becomes activated Yeast Two-Hybrid and cDNA Cloning
during the preceeding steps of the TNF- and IL-1-trig- DNA encoding NIK (Song et al., 1997) was cloned into the GAL4
DNA-binding vector pGTB9 (Clontech). The resulting plasmid,gered NF-kB activation pathways is mechanistically not
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pGTB9-NIK, was used as bait in a two-hybrid screen of a human B In Vitro Phosphorylation Assays
Flag epitope±tagged CHUK was expressed for 24 hours in 293 cellscell cDNA library (Clontech) in S. cerevisiae Y190 according to the
Matchmaker Two-Hybrid System Protocol (Clontech). Positive yeast alone or with Myc epitope±tagged NIK or NIK(KK429±430AA) as described
above. Cell lysates were immunoprecipitated with anti-Flag mono-clones were selected for prototrophy for histidine and expression
of b-galactosidase. Yeast DNA was recovered and transformed into clonal antibody affinity resin (Eastman Kodak Company) and bound
proteins eluted with 30 ml of cell lysis buffer containing Flag peptideE. coli KC8 cells carrying a leuB mutation (provided by Dr. Li Zhu,
Clontech). Plasmids containing cDNA clones were characterized by (300 mg/ml). Flag epitope±tagged CHUK(K44A) was expressed and
purified similarly. In vitro kinase reactions were performed with 1 mlDNA sequencing. Full-length CHUK cDNA was obtained by screen-
ing a human Jurkat T cell cDNA library in lZAP by standard methods of CHUK-containing eluate and 0.5 mg of bacterially expressed IkB
proteins in 15 ml of kinase buffer containing 20 mM Tris±HCl (pH(Sambrook et al., 1989).
7.6), 20 mM magnesium chloride, 20 mM b-glycerophosphate, 20
mM p-nitrophenylphosphate, 1 mM EDTA, 1 mM sodium orthovana-Expression Vectors
date, 0.4 mM PMSF, 1 mM ATP, 20 mM creatine phosphate, and 5Mammalian cell expression vectors encoding TRAF2, NIK, and
mCi of [g-32P]-ATP at 378C for 30 minutes. Samples were analyzedNIK(KK429±430AA) have been described previously (Rothe et al., 1995a;
by 10% SDS±PAGE and autoradiography.Song et al., 1997). The control expression plasmid pRK5, the NF-
kB-dependent E-selectin-luciferase reporter gene plasmid, and
pRSV-b-gal were also described previously (Schall et al., 1990; Acknowledgments
Schindler and Baichwal, 1994; Rothe et al., 1995a). The expression
vectors for IkB-a and IkB-a (S32,36A), p65 and p50, were provided by Correspondence should be addressed to M. R. (e-mail: rothe@
Drs. Takeshi Kurama, Vijay Baichval, and Patrick Baeuerle. Expres- tularik.com). We thank Takeshi Kurama, Vijay Baichval, Patrick
sion vectors for Flag and Myc epitope±tagged CHUK were con- Baeuerle, and Li Zhu for various reagents, and Keith Williamson
structed in-frame with DNA encoding an N-terminal Flag or Myc for DNA sequencing. We also thank Patrick Baeuerle for helpful
epitope in pRK. Expression plasmids encoding CHUK(K44A) and discussions throughout this project.
CHUK(307±745) were generated by polymerase chain reaction.
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